HK1092803A1 - Benzoyl amino pyridyl carboxylic acid derivatives as glucokinase activators - Google Patents

Benzoyl amino pyridyl carboxylic acid derivatives as glucokinase activators

Info

Publication number
HK1092803A1
HK1092803A1 HK06113502A HK06113502A HK1092803A1 HK 1092803 A1 HK1092803 A1 HK 1092803A1 HK 06113502 A HK06113502 A HK 06113502A HK 06113502 A HK06113502 A HK 06113502A HK 1092803 A1 HK1092803 A1 HK 1092803A1
Authority
HK
Hong Kong
Prior art keywords
carboxylic acid
acid derivatives
glucokinase activators
benzoyl amino
pyridyl carboxylic
Prior art date
Application number
HK06113502A
Other languages
English (en)
Inventor
Johnstone Craig
Mckerrecher Darren
Pike Kurt Gordon
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HK1092803A1 publication Critical patent/HK1092803A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Feeding And Guiding Record Carriers (AREA)
  • Bidet-Like Cleaning Device And Other Flush Toilet Accessories (AREA)
  • External Artificial Organs (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK06113502A 2003-11-29 2006-12-07 Benzoyl amino pyridyl carboxylic acid derivatives as glucokinase activators HK1092803A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0327760.5A GB0327760D0 (en) 2003-11-29 2003-11-29 Compounds
PCT/GB2004/004956 WO2005054233A1 (en) 2003-11-29 2004-11-25 Benzoyl amino pyridil carboxylic acid derivatives as gluokinase activators

Publications (1)

Publication Number Publication Date
HK1092803A1 true HK1092803A1 (en) 2007-02-16

Family

ID=29798044

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06113502A HK1092803A1 (en) 2003-11-29 2006-12-07 Benzoyl amino pyridyl carboxylic acid derivatives as glucokinase activators

Country Status (10)

Country Link
US (1) US20090018157A1 (es)
EP (1) EP1689741B1 (es)
JP (1) JP2007512300A (es)
CN (1) CN1886401A (es)
AT (1) ATE386031T1 (es)
DE (1) DE602004011814T2 (es)
ES (1) ES2299886T3 (es)
GB (1) GB0327760D0 (es)
HK (1) HK1092803A1 (es)
WO (1) WO2005054233A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0102299D0 (sv) 2001-06-26 2001-06-26 Astrazeneca Ab Compounds
GB0226930D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
GB0226931D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
EP2048137A1 (en) * 2004-02-18 2009-04-15 AstraZeneca AB Benzamide derivatives and their use as glucokinase activating agents.
TW200600086A (en) * 2004-06-05 2006-01-01 Astrazeneca Ab Chemical compound
TW200714597A (en) * 2005-05-27 2007-04-16 Astrazeneca Ab Chemical compounds
US20110053910A1 (en) * 2005-07-09 2011-03-03 Mckerrecher Darren 2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes
BRPI0622262A2 (pt) 2005-07-09 2011-08-09 Astrazeneca Ab composto, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, processo para a preparação de um composto
JP2007063225A (ja) 2005-09-01 2007-03-15 Takeda Chem Ind Ltd イミダゾピリジン化合物
WO2007039177A2 (en) 2005-09-29 2007-04-12 Sanofi-Aventis Phenyl- and pyridinyl- 1, 2 , 4 - oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals
EP2001875A2 (en) 2006-03-08 2008-12-17 Takeda San Diego, Inc. Glucokinase activators
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
WO2007143434A2 (en) 2006-05-31 2007-12-13 Takeda San Diego, Inc. Indazole and isoindole derivatives as glucokinase activating agents
TW200825060A (en) 2006-10-26 2008-06-16 Astrazeneca Ab Chemical compounds
JP5419706B2 (ja) 2006-12-20 2014-02-19 タケダ カリフォルニア インコーポレイテッド グルコキナーゼアクチベーター
WO2008116107A2 (en) 2007-03-21 2008-09-25 Takeda San Diego, Inc. Piperazine derivatives as glucokinase activators
WO2010015849A2 (en) 2008-08-04 2010-02-11 Astrazeneca Ab Therapeutic agents 414
GB0902406D0 (en) * 2009-02-13 2009-04-01 Astrazeneca Ab Crystalline polymorphic form
GB0902434D0 (en) * 2009-02-13 2009-04-01 Astrazeneca Ab Chemical process
AR076221A1 (es) * 2009-04-09 2011-05-26 Astrazeneca Ab Derivado de pirazol [4,5-e] pirimidina y su uso para tratar diabetes y obesidad
AR076220A1 (es) 2009-04-09 2011-05-26 Astrazeneca Ab Derivados de pirazol [4,5 - e] pirimidina

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0102300D0 (sv) * 2001-06-26 2001-06-26 Astrazeneca Ab Compounds

Also Published As

Publication number Publication date
GB0327760D0 (en) 2003-12-31
DE602004011814D1 (en) 2008-03-27
EP1689741A1 (en) 2006-08-16
US20090018157A1 (en) 2009-01-15
WO2005054233A1 (en) 2005-06-16
EP1689741B1 (en) 2008-02-13
DE602004011814T2 (de) 2009-02-05
JP2007512300A (ja) 2007-05-17
CN1886401A (zh) 2006-12-27
ES2299886T3 (es) 2008-06-01
ATE386031T1 (de) 2008-03-15

Similar Documents

Publication Publication Date Title
HK1092803A1 (en) Benzoyl amino pyridyl carboxylic acid derivatives as glucokinase activators
NO20062269L (no) Pyridin-karboksylsyrederivater som glucokinasemodulatorer
MXPA05011411A (es) 1,4-diazepinas sustituidas y usos de las mismas.
HK1062888A1 (en) Vinyl phenyl derivatives as glk activators
NO20075169L (no) Nye imidazo (1,5-A)pyndindenvater, fremgangsmate for fremstilling og farmasoytiske sammensetninger som inneholder samme.
TW200606151A (en) Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
TW200603799A (en) Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
TW200602028A (en) Compounds
JO2353B1 (en) New derivatives of mixed-ring fluoroglycosides and drugs containing these compounds and their use
TW200604186A (en) Compounds
NO20052496L (no) Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og anvendelse derav som medikamenter.
NZ536734A (en) Spiroindolinepiperidine derivatives
MXPA05011710A (es) Derivados de pirimidina con actividad de crf.
TW200616636A (en) Novel compounds
AU2003246100A1 (en) Amide derivative
MXPA03005822A (es) Compuestos heterociclicos que tienen actividad antibacteriana, proceso para su preparacion y composiciones farmaceuticas que los contienen.
SG171471A1 (en) New benzimidazole derivatives
MXPA05008584A (es) Compuestos heterociclicos utiles como activadores de nurr-1.
HUP0100865A2 (hu) Meta-azaciklusos csoporttal N-szubsztituált amino-benzoesav-vegyületek és származékaik mint integrin antagonista hatóanyagok, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
MX2022000854A (es) Derivados de 2-morfolinopiridina sustituidos como inhibidores de la cinasa atr.
NO20070157L (no) Substituerte diketopiperaziner som oksytocinantagonister
TW200606153A (en) Process for producing pyridine derivatives of Nk-1 receptor antagonist
ATE505462T1 (de) Neue biologischaktive molekü le
Kline et al. Tethered thiazolidinone dimers as inhibitors of the bacterial type III secretion system
MXPA04005426A (es) Derivados de pirazol de anillos fuisionados.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20111125